Quick Takeaways
- Sio Capital Management, LLC filed SCHEDULE 13G/A for Bright Minds Biosciences Inc. Common Shares (DRUG).
- Disclosed ownership: 2.7%.
- Date of event: 30 Sep 2025.
Sio Capital Management, LLC - 30 Sep 2025 SCHEDULE 13G/A Report for Bright Minds Biosciences Inc. Common Shares (DRUG)
- Filing Manager
- Sio Capital Management, LLC
- Reporting Manager
- Sio Capital Management, LLC
- Symbol
- DRUG
- Shares outstanding
- 7,091,599 shares
- Disclosed Ownership
- 190,764 shares
- Ownership
- 2.7%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 Nov 2025, 08:00:21 UTC
- Date of event
- 30 Sep 2025
- Previous filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Sio Capital Management, LLC disclosed 2.7% ownership in Bright Minds Biosciences Inc. Common Shares (DRUG) on 30 Sep 2025."
What Changed
- Previous schedule filing date: 13 Aug 2025.
- Current filing was accepted on 12 Nov 2025, 08:00.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sio Capital Management, LLC | 2.7% | 190,764 | 0 | 190,764 | /s/ Jin W. Lee | Chief Compliance Officer |